Delivery Order SPE2DB22D2009-SPE2DB25FL8LE

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,357.86, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 20, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,098.36, is a Firm Fixed Price Delivery Order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.75 firm fixed-price delivery order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. This award is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,209.32 delivery order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,862.13 firm fixed-price delivery order is for the supply of AIMOVIG 140 MG/ML autoinjectors. The contract has a completion date of September 12, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,496.94 delivery order contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of February 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,851.20, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has a completion date of February 24, 2025 and is a firm fixed price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.31 Firm Fixed Price Delivery Order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,851.38 firm fixed-price delivery order is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML. The firm-fixed-price delivery order, valued at $1,357.86, has a completion date of November 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8LE
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,385.57 fixed-price delivery order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/1/25, 7:57 AM